KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biogen (BIIB) Other Operating Expenses (2016 - 2025)

Biogen (BIIB) has 17 years of Other Operating Expenses data on record, last reported at -$33.6 million in Q4 2025.

  • For Q4 2025, Other Operating Expenses fell 112.56% year-over-year to -$33.6 million; the TTM value through Dec 2025 reached -$33.6 million, down 137.92%, while the annual FY2025 figure was -$33.6 million, 137.92% down from the prior year.
  • Other Operating Expenses reached -$33.6 million in Q4 2025 per BIIB's latest filing, down from $68.4 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $833.1 million in Q4 2023 and bottomed at -$263.3 million in Q1 2022.
  • Average Other Operating Expenses over 5 years is $89.5 million, with a median of $24.7 million recorded in 2021.
  • Peak YoY movement for Other Operating Expenses: tumbled 956.25% in 2022, then skyrocketed 6181.02% in 2023.
  • A 5-year view of Other Operating Expenses shows it stood at $1.6 million in 2021, then crashed by 956.25% to -$13.7 million in 2022, then surged by 6181.02% to $833.1 million in 2023, then tumbled by 67.89% to $267.5 million in 2024, then tumbled by 112.56% to -$33.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Operating Expenses were -$33.6 million in Q4 2025, $68.4 million in Q2 2025, and -$68.4 million in Q1 2025.